home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  38th ERA-EDTA Congress  
  March 01, 2001

Others

 
     
  ERA-EDTA, Vienna, Austria
24-27 June 2001


Monday 25/06/2001


GUEST LECTURE 1
Angiogenesis
HALL A 8.30 - 9.00


ERA-EDTA Registry
HALL D 8.30 - 9.00


Symposium 1
Acute renal failure in the new millennium
Pathophysiology of ARF in the intensive care unit
Extracorporeal treatment modalities and dosage in ARF patients: continuous versus discontinuous
The role of the nephrologist in the management of ARF
HALL A 9.00 - 10.30


Symposium 2
New Biocompatible PD solutions: the future is now
Local effects of new PD solutions: cellular and molecular aspects
Systemic effects of new PD solutions
Clinical experience with combined use of the new solutions
HALL B 9.00 - 10.30


Controversy 1
New Vitamine D analogues - Do they offer therapeutic advantages?
Hot Topics
HALL C 9.00 - 10.30


Symposium 3
Treatment of systemic vasculitis
Current therapy and complications in systemic vasculitis
The results of the CYCAZERAM and NORAM studies
New drug regimens in the treatment of systemic vasculitis
HALL D 9.00 - 10.30


Symposium 4
Allograft rejection: new insights
Humoral rejection
Subclinical rejection
Chronic rejection
HALL E 9.00 - 10.30



Symposium 5
Treatment resistance in progressive renal function loss
Interindividual variability and treatment resistance- dose response and treatment resistance
Gene and environment interaction in relation to treatment resistance
Combination therapy for treatment resistance in renal disease
Dietary measures to overcome treatment resistance
HALL F 9.00 - 10.30


Symposium 6
Transport mechanisms of the proximal tubule
Molecular pathophysiology of renal transport
Endocytosis of the proximal tubules
Proximal tubulus divalent anion transport
HALL G 9.00 - 10.30


Symposium 7
Hyperhomocysteinaemia in renal disease
Disturbance of homocysteine metabolism in renal disease
Laboratory analyses and molecular genetics of homocysteine
Clinical aspects of hyperhomocysteinemia in renal disease
HALL H 9.00 - 10.30


GUEST LECTURE 2
Challenges to achieve clinical transplantation tolerance
HALL A 14.00 - 14.30


Symposium 8
The genetics of hypertension and renal diseases
Molecular genetics of hypertension
New genes controlling phosphaturia
Molecular genetics of diabetic nephropathy
HALL A 16.30 - 18.00


Symposium 9
Secondary hyperparathyroidism and renal bone disease
New aspects of parathyroid physiology and pathophysiology
Which biochemical parameters are useful for the diagnosis of renal bone disease?
Clinical experience with calcimimetics
HALL B 16.30 - 18.00


Symposium 10
New insights into progression: role of renin-angiotensin-aldosterone system (RAAS)
Role of RAAS in interstitial damage
Aldosterone in progressive renal disease
ACE polymorphism - an introduction of pharmacogenetics in nephrology
HALL C 16.30 - 18.00


Symposium 11
Ischemic heart disease in chronic renal failure
Diagnostic problems in the uraemic patient with coronary heart disease
Clinical outcome following coronary stenting or balloon angioplasty in dialysis patients
Ischemic heart disease risk after renal transplantation
HALL D 16.30 - 18.00


Symposium 12
Transplantation: new developments
New immunosuppressive drugs
Gene polymorphisms and renal transplantation
Immune tolerance and gene therapy in transplantation
HALL E 16.30 - 18.00


Symposium 13
New advances in Continuous Flow Peritoneal Dialysis (CFPD)
Background and need for CFPD: a critical reappraisal
Improved small solute removal: predictions vs experimental results
Preliminary experience with CFPD
HALL F 16.30 - 18.00



Symposium 14
Renal replacement therapies of the future
Bioartificial kidney
Metanephroi transplantation
Tissue Engineered Kidney
HALL G 16.30 - 18.00


Symposium 15
New pathogenetic and therapeutic aspects of diabetic nephropathy
Cellular molecular defects in diabetic nephropathy
The polyol pathway in diabetic nephropathy
Novel therapeutic targets in diabetic nephropathy
HALL H 16.30 - 18.00

Tuesday 26/06/2001



GUEST LECTURE 3
TONY RAINE MEMORIAL LECTURE ON CARDIOVASCULAR DISEASE
Nephroangiosclerosis: a journey through blood pressure, atherosclerosis, aging and genes
HALL A 8.30 - 9.00


ERA-EDTA Registry 2
HALL D 8.30 - 9.00


Symposium 16
On-line monitoring: targets and devices
Dialysis dose and sodium balance
Blood volume monitoring
Urea sensors and beyond
HALL A 9.00 - 10.30


Symposium 17
Treatment of diabetic nephropathy in the new millennium
AGEs counteraction
Glycosaminoglycans
Comparison of different antihypertensive strategies: study in type II diabetics
HALL B 9.00 - 10.30


Symposium 18
Microalbuminuria: a predictor of cardiovascular and renal risk
Predictive value in the general population and in essential hypertension
Predictive value in type II diabetes
Endothelial dysfunction and the kidney
HALL C 9.00 - 10.30


Symposium 19
Hypertension and the kidney
Evaluation of renal function in large hypertension trials: a systematic review
Target blood pressure in high risk patient population
Renal disease progression and ACE inhibition: a meta-analysis across the Atlantic
HALL D 9.00 - 10.30


Symposium 20
Transplantation: expanding the donor pool?
The marginal donor
The non-heart-beating kidney donor
Old kidneys for aging recipients?
Ethical selection of living kidney donors
HALL E 9.00 - 10.30


Controversy 2
Haematocrit normalisation in dialysis patients: yes or no
Anemia management in the U.S. - A call to action
HALL F 9.00 - 10.30


Symposium 21
New insights in extracellular matrix
Renal pathology and extracellular matrix
Matrix metabolism: the role of metalloproteinases
Control of extracellular matrix assembly
HALL G 9.00 - 10.30


EKRA
HALL H 9.00 - 10.30


EKRA
HALL H 11.00 - 12.30


GUEST LECTURE 4
Sexual hormonal replacement therapy in chronic renal failure
HALL A 14.00 - 14.30


EKRA
HALL H 14.30 - 16.00

Wednesday 27/06/2001




GUEST LECTURE 5
Aquaporins in physiology and pathology
HALL A 8.30 - 9.00


Symposium 22
Cardiovascular risk factors in renal disease
Serum creatinine as a cardiovascular risk factor
Role of hyperphosphatemia and hypercalcemia in the development of vascular calcifications
Hyperphosphatemia as a mortality risk factor for dialysis patients
HALL A 11.00 - 12.30


Symposium 23
Different approaches in vascular access management
Surgical procedures to maintain vascular access patency
Interventional radiology for vascular access patency
Pharmacological approach to vascular access thrombosis
Gene therapy for vein grafts
HALL C 11.00 - 12.30


Controversy 3
Atherosclerotic renal artery stenosis: angioplasty versus drug treatment
HALL D 11.00 - 12.30


Symposium 24
Indication for combined transplants
Kidney - Heart
Kidney - Liver
Kidney - Pancreas
HALL E 11.00 - 12.30


Symposium 25
Clinical epidemiology in nephrology: the basics
Experimental and observational studies and research strategies
Meta-analysis
Survival analysis: a primer
HALL F 11.00 - 12.30


Symposium 26
Best Practice Guidelines - HD and PD
HALL G 11.00 - 12.30
 
 
Organized by: ERA-EDTA Congress Office
Invited Speakers: not available for the moment
 
Deadline for Abstracts: 31/01/2001
 
Registration: EARLY PRE-REGISTRATION 28/02/2001

LATE PRE- REGISTRATION 15/05/2001



AFTER 15/05/2001 ONLY ON-SITE REGISTRATIONS WILL BE POSSIBLE
E-mail: congress@euromeetings.it
 
  Posted by:   Francesca Trebelli  
Host: adsl-164-223.38-151.net24.it
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.